unknown
Stage
1
Investors
About
Immunisbiomedical is a clinical-stage biotech company developing first-in-class multi-active biologic therapeutics targeting age-related muscle and metabolic diseases to improve muscle function and healthy aging.
Explore Immunis Biomedical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.